The histone variant H2A.Bbd is enriched at sites of DNA synthesis

Nucleic Acids Research

Volumn 42, Issue 10, 2014, Pages 6405-6420

  Sansoni, Viola ^a   Casas Delucchi, Corella S ^b,d   Rajan, Malini ^b   Schmidt, Andreas ^a   Bönisch, Clemens ^a,e   Thomae, Andreas W ^a   Staege, Martin S ^c   Hake, Sandra B ^a   Cardoso, M Cristina ^b   Imhof, Axel ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; HISTONE H2A; HISTONE H2A BBD; HISTONE MACROH2A.1.2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL NUCLEUS; CHROMATIN; CHROMATIN STRUCTURE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA SYNTHESIS; EMBRYO; FEMALE; GENE ONTOLOGY; HUMAN; HUMAN CELL; LYMPHOMA CELL; MOUSE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN TARGETING; PROTEOMICS; REPLISOME; SOMATIC CELL; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; CHROMATIN; DNA; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FEMALE; GENETIC VARIATION; HISTONES; HUMANS; MICE;

EID: 84903154988     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku303     Document Type: Article

References (60)

1. LeRoy, G., Floudas, C.A., Hake, S.B. and Garcia, B.A. (2011) Proteomic interrogation of human chromatin. PLoS One.
2. Khoudoli, G.A., Gillespie, P.J., Stewart, G., Andersen, J.S., Swedlow, J.R. and Blow, J.J. (2008) Temporal profiling of the chromatin proteome reveals system-wide responses to replication inhibition. Curr. Biol., 18, 838-843.
3. Dutta, B., Adav, S.S., Koh, C.G., Lim, S.K., Meshorer, E. and Sze, S.K. (2012) Elucidating the temporal dynamics of chromatin-associated protein release upon DNA digestion by quantitative proteomic approach. J. Proteomics, 75, 5493-5506.
4. Ohta, S., Bukowski-Wills, J.-C., Sanchez-Pulido, L., Alves, F.de, L., Wood, L., Chen, Z.A., Platani, M., Fischer, L., Hudson, D.F., Ponting, C.P. et al. (2010) The protein composition of mitotic chromosomes determined using multiclassifier combinatorial proteomics. Cell, 142, 810-821.
5. Chu, D.S., Liu, H., Nix, P., Wu, T.F., Ralston, E.J., Yates, J.R. and Meyer, B.J. (2006) Sperm chromatin proteomics identifies evolutionarily conserved fertility factors. Nature, 443, 101-105.
6. Franklin, S., Chen, H., Mitchell-Jordan, S., Ren, S., Wang, Y. and Vondriska, T.M. (2012) Quantitative analysis of the chromatin proteome in disease reveals remodeling principles and identifies high mobility group protein B2 as a regulator of hypertrophic growth. Mol. Cell. Proteomics, 11, M111.014258-M111.014258.
7. Talbert, P.B., Ahmad, K., Almouzni, G., Ausió, J., Berger, F., Bhalla, P.L., Bonner, W.M., Cande, W.Z., Chadwick, B.P., Chan, S.W.L. et al. (2012) A unified phylogeny-based nomenclature for histone variants. Epigenet. Chromatin, 5, 7-26.
8. Hake, S.B. and Allis, C.D. (2006) Histone H3 variants and their potential role in indexing mammalian genomes: the "H3 barcode hypothesis". Proc. Natl. Acad. Sci. U.S.A., 103, 6428-6435.
9. Schneider, T.D., Arteaga-Salas, J.M., Mentele, E., David, R., Nicetto, D., Imhof, A. and Rupp, R.A.W. (2011) Stage-specific histone modification profiles reveal global transitions in the Xenopus embryonic epigenome. PLoS One, 6, e22548.
10. Bhattacharya, D., Talwar, S., Mazumder, A. and Shivashankar, G.V. (2009) Spatio-temporal plasticity in chromatin organization in mouse cell differentiation and during Drosophila embryogenesis. Biophys. J., 96, 3832-3839.
11. Meshorer, E., Yellajoshula, D., George, E., Scambler, P.J., Brown, D.T. and Misteli, T. (2006) Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev. Cell, 10, 105-116.
12. Dai, B. and Rasmussen, T.P. (2007) Global epiproteomic signatures distinguish embryonic stem cells from differentiated cells. Stem Cells, 25, 2567-2574.
13. Wu, G., Broniscer, A., McEachron, T.A., Lu, C., Paugh, B.S., Becksfort, J., Qu, C., Ding, L., Huether, R., Parker, M. et al. (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet., 44, 251-253.
14. Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D.T.W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A.M., Quang, D.-A.K., Tönjes, M. et al. (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature, doi:10.1038/nature10833.
15. Lacoste, N., Woolfe, A., Tachiwana, H., Garea, A.V., Barth, T., Cantaloube, S., Kurumizaka, H., Imhof, A. and Almouzni, G. (2014) Mislocalization of the centromeric histone variant CenH3/CENP-A in human cells depends on the chaperone DAXX. Mol. Cell, 53, 631-644.
16. Tomonaga, T., Matsushita, K., Yamaguchi, S., Oohashi, T., Shimada, H., Ochiai, T., Yoda, K. and Nomura, F. (2003) Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer. Cancer Res., 63, 3511-3516.
17. Winkler, C., Steingrube, D.S., Altermann, W., Schlaf, G., Max, D., Kewitz, S., Emmer, A., Kornhuber, M., Banning-Eichenseer, U. and Staege, M.S. (2012) Hodgkin's lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses. Cancer Immunol. Immunother., 61, 1769-1779.
18. Kapoor, A., Goldberg, M.S., Cumberland, L.K., Ratnakumar, K., Segura, M.F., Emanuel, P.O., Menendez, S., Vardabasso, C., LeRoy, G., Vidal, C.I. et al. (2010) The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature, 468, 1105-1109.
19. Svotelis, A., Gévry, N., Grondin, G. and Gaudreau, L. (2010) H2A.Z overexpression promotes cellular proliferation of breast cancer cells. Cell Cycle, 9, 364-370.
20. Hua, S., Kallen, C.B., Dhar, R., Baquero, M.T., Mason, C.E., Russell, B.A., Shah, P.K., Liu, J., Khramtsov, A., Tretiakova, M.S. et al. (2008) Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol. Syst. Biol., 4, 188.
21. Pehrson, J.R. and Fried, V.A. (1992) MacroH2A, a core histone containing a large nonhistone region. Science, 257, 1398-1400.
22. Costanzi, C. and Pehrson, J.R. (1998) Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature, 393, 599-601.
23. Mietton, F., Sengupta, A.K., Molla, A., Picchi, G., Barral, S., Heliot, L., Grange, T., Wutz, A. and Dimitrov, S. (2009) Weak but uniform enrichment of the histone variant macroH2A1 along the inactive X chromosome. Mol. Cell. Biol., 29, 150-156.
24. Gamble, M.J., Frizzell, K.M., Yang, C., Krishnakumar, R. and Kraus, W.L. (2010) The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. Genes Dev., 24, 21-32.
25. Agelopoulos, M. and Thanos, D. (2006) Epigenetic determination of a cell-specific gene expression program by ATF-2 and the histone variant macroH2A. EMBO J., 25, 4843-4853.
26. Buschbeck, M., Uribesalgo, I., Wibowo, I., Rué, P., Martin, D., Gutierrez, A., Morey, L., Guigo, R., López-Schier, H. and Di Croce, L. (2009) The histone variant macroH2A is an epigenetic regulator of key developmental genes. Nat. Struct. Mol. Biol., 16, 1074-1079.
27. Abbott, D.W., Chadwick, B.P., Thambirajah, A.A. and Ausió, J. (2005) Beyond the Xi: macroH2A chromatin distribution and post-translational modification in an avian system. J. Biol. Chem., 280, 16437-16445.
28. Angelov, D., Molla, A., Perche, P.-Y., Hans, F., Cote, J., Khochbin, S., Bouvet, P. and Dimitrov, S. (2003) The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling. Mol. Cell, 11, 1033-1041.
29. Tolstorukov, M.Y., Goldman, J.A., Gilbert, C., Ogryzko, V., Kingston, R.E. and Park, P.J. (2012) Histone variant H2A. Bbd Is associated with active transcription and mRNA processing in human cells. Mol. Cell, 47, 1-12.
30. Ioudinkova, E.S., Barat, A., Pichugin, A., Markova, E., Sklyar, I., Pirozhkova, I., Robin, C., Lipinski, M., Ogryzko, V., Vassetzky, Y.S. et al. (2012) Distinct distribution of ectopically expressed histone variants H2A. Bbd and MacroH2A in open and closed chromatin domains. PLoS One, 7, e47157.
31. Chadwick, B.P. and Willard, H.F. (2001) A novel chromatin protein, distantly related to histone H2A, is largely excluded from the inactive X chromosome. J. Cell Biol., 152, 375-384.
32. Drexler, H.G. (2010) Guide to leukemia-lymphoma cell lines, 2nd edn. German Collection of Microorganisms and Cell Cultures, Braunschweig.
33. Gautier, T., Abbott, D.W., Molla, A., Verdel, A., Ausió, J. and Dimitrov, S. (2004) Histone variant H2ABbd confers lower stability to the nucleosome. EMBO Rep., 5, 715-720.
34. Ishibashi, T., Li, A., Eirín-López, J.M., Zhao, M., Missiaen, K., Abbott, D.W., Meistrich, M., Hendzel, M.J. and Ausió, J. (2010) H2A. Bbd: an X-chromosome-encoded histone involved in mammalian spermiogenesis. Nucleic Acids Res., 38, 1780-1789.
35. Soboleva, T.A., Nekrasov, M., Pahwa, A., Williams, R., Huttley, G.A. and Tremethick, D.J. (2011) A unique H2A histone variant occupies the transcriptional start site of active genes. Nat. Struct. Mol. Biol., 19, 25-30.
36. Loyola, A., Bonaldi, T., Roche, D., Imhof, A. and Almouzni, G. (2006) PTMs on H3 variants before chromatin assembly potentiate their final epigenetic state. Mol. Cell, 24, 309-316.
37. Polo, S.E., Roche, D. and Almouzni, G. (2006) New histone incorporation marks sites of UV repair in human cells. Cell, 127, 481-493.
38. Lamprecht, B., Walter, K., Kreher, S., Kumar, R., Hummel, M., Lenze, D., Köchert, K., Bouhlel, M.A., Richter, J., Soler, E. et al. (2010) Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat. Med., 16, 571-579.
39. Bao, Y., Konesky, K., Park, Y.-J., Rosu, S., Dyer, P.N., Rangasamy, D., Tremethick, D.J., Laybourn, P.J. and Luger, K. (2004) Nucleosomes containing the histone variant H2A. Bbd organize only 118 base pairs of DNA. EMBO J., 23, 3314-3324.
40. Gaspar-Maia, A., Qadeer, Z.A., Hasson, D., Ratnakumar, K., Leu, N.A., LeRoy, G., Liu, S., Costanzi, C., Valle-Garcia, D., Schaniel, C. et al. (2013) MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency. Nat. Commun., 4, 1565-1578.
41. Shukla, M.S., Syed, S.H., Goutte-Gattat, D., Richard, J.L.C., Montel, F., Hamiche, A., Travers, A., Faivre-Moskalenko, C., Bednar, J., Hayes, J.J. et al. (2011) The docking domain of histone H2A is required for H1 binding and RSC-mediated nucleosome remodeling. Nucleic Acids Res., 39, 2559-2570.
42. Pasque, V., Radzisheuskaya, A., Gillich, A., Halley-Stott, R.P., Panamarova, M., Zernicka-Goetz, M., Surani, M.A. and Silva, J.C.R. (2013) Histone variant macroH2A marks embryonic differentiation in vivo and acts as an epigenetic barrier to induced pluripotency. J. Cell Sci., 125, 6094-6104.
43. Govin, J., Escoffier, E., Rousseaux, S., Kuhn, L., Ferro, M., Thevenon, J., Catena, R., Davidson, I., Garin, J., Khochbin, S. et al. (2007) Pericentric heterochromatin reprogramming by new histone variants during mouse spermiogenesis. J. Cell Biol., 176, 283-294.
44. Wolf, J., Kapp, U., Bohlen, H., Kornacker, M., Schoch, C., Stahl, B., Mücke, S., Kalle von, C., Fonatsch, C., Schaefer, H.E. et al. (1996) Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Blood, 87, 3418-3428.
45. Diehl, V., Kirchner, H.H., Schaadt, M., Fonatsch, C., Stein, H., Gerdes, J. and Boie, C. (1981) Hodgkin's disease: establishment and characterization of four in vitro cell lies. J. Cancer Res. Clin. Oncol., 101, 111-124.
46. Drexler, H.G., Gaedicke, G., Lok, M.S., Diehl, V. and Minowada, J. (1986) Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles. Leuk. Res., 10, 487-500.
47. Kamesaki, H., Fukuhara, S., Tatsumi, E., Uchino, H., Yamabe, H., Miwa, H., Shirakawa, S., Hatanaka, M. and Honjo, T. (1986) Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. Blood, 68, 285-292.
48. Foell, J.L., Volkmer, I., Giersberg, C., Kornhuber, M., Horneff, G. and Staege, M.S. (2008) Loss of detectability of Charcot-Leyden crystal protein transcripts in blood cells after treatment with dimethyl sulfoxide. J. Immunol. Methods, 339, 99-103.
49. Sporbert, A., Domaing, P., Leonhardt, H. and Cardoso, M.C. (2005) PCNA acts as a stationary loading platform for transiently interacting Okazaki fragment maturation proteins. Nucleic Acids Res., 33, 3521-3528.
50. Casas-Delucchi, C.S., van Bemmel, J.G., Haase, S., Herce, H.D., Nowak, D., Meilinger, D., Stear, J.H., Leonhardt, H. and Cardoso, M.C. (2012) Histone hypoacetylation is required to maintain late replication timing of constitutive heterochromatin. Nucleic Acids Res., 40, 159-169.
51. Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W. and Selbach, M. (2011) Global quantification of mammalian gene expression control. Nature, 473, 337-342.
52. Vizcaíno, J.A., Côté, R.G., Csordas, A., Dianes, J.A., Fabregat, A., Foster, J.M., Griss, J., Alpi, E., Birim, M., Contell, J. et al. (2013) The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res., 41, D1063-D1069.
53. Cox, J. and Mann, M. (2012) 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinformatics, 13(Suppl. 16), S12.
54. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. JSTOR Series B (Methodological), 57, 289-300.
55. Huang, D.W., Sherman, B. and Lempicki, R. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res., 37, 1-13.
56. Huang, D.W., Sherman, B.T. and Lempicki, R. (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protocols, 4, 44-57.
57. Neumann, I., Foell, J.L., Bremer, M., Volkmer, I., Korholz, D., Burdach, S. and Staege, M.S. (2010) Retinoic acid enhances sensitivity of neuroblastoma cells for imatinib mesylate. Pediatr. Blood Cancer, 55, 464-470.
58. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R.A., Olsen, J.V. and Mann, M. (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res., 10, 1794-1805.
59. Leduc, F., Maquennehan, V., Nkoma, G.B. and Boissonneault, G. (2008) DNA damage response during chromatin remodeling in elongating spermatids of mice. Biol. Reprod., 78, 324-332.
60. Yeoh, K.-W. and Mikhaeel, N.G. (2011) Role of radiotherapy in modern treatment of Hodgkin's lymphoma. Adv. Hematol., 2011, 258797.